NISA INVESTMENT ADVISORS, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$84,752
+88.4%
533
+67.6%
0.00%
Q2 2023$44,984
+32497.1%
318
-61.3%
0.00%
-100.0%
Q1 2023$138
+155.6%
822
+157.7%
0.00%
Q4 2022$54
-99.9%
3190.0%0.00%
Q3 2022$58,000
-13.4%
319
-22.9%
0.00%
-100.0%
Q2 2022$67,000
-50.0%
414
-42.0%
0.00%0.0%
Q1 2022$134,000
-69.5%
714
-67.8%
0.00%
-66.7%
Q4 2021$440,000
-28.7%
2,218
+3.9%
0.00%
-25.0%
Q3 2021$617,000
-28.3%
2,135
-50.4%
0.00%
-20.0%
Q2 2021$860,000
+0.4%
4,307
-2.3%
0.01%0.0%
Q1 2021$857,000
+11.6%
4,407
+10.0%
0.01%0.0%
Q4 2020$768,000
+85.1%
4,007
+42.6%
0.01%
+66.7%
Q3 2020$415,000
-46.9%
2,810
-55.6%
0.00%
-57.1%
Q2 2020$781,000
+2010.8%
6,322
+1563.7%
0.01%
Q1 2020$37,000
-14.0%
380
-19.1%
0.00%
Q4 2019$43,000
+95.5%
470
+62.1%
0.00%
Q3 2019$22,000
+29.4%
290
+45.0%
0.00%
Q2 2019$17,000
+41.7%
2000.0%0.00%
Q1 2019$12,000
-20.0%
200
-52.4%
0.00%
Q4 2017$15,000
-6.2%
4200.0%0.00%
Q3 2017$16,000
-5.9%
4200.0%0.00%
Q2 2017$17,000
+13.3%
4200.0%0.00%
Q1 2017$15,000
-40.0%
420
-47.5%
0.00%
Q4 2016$25,000
+19.0%
800
+14.3%
0.00%
Q3 2016$21,000
+10.5%
7000.0%0.00%
Q2 2016$19,0007000.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders